Sign in

CIK 0001275187 · Accelerated filer

ANGIODYNAMICS INC

Sign in to watch
Ticker
ANGO
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
May 31
Incorporated
DE
Entity type
operating
EIN
113146460
Phone
5187981215
Business address
14 PLAZA DRIVE, LATHAM, NY, 12110
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$310,688
in 1 filing

Net −$310,688. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Trowbridge Stephen A −$311K EVP and CFO sold 8% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-07-17 Tarnoff Michael E Director Grant or award +20,541 65,703
2024-07-17 Clemmer James C President and CEO Grant or award +105,811 644,877
2024-07-17 Clemmer James C President and CEO Grant or award · Performance Right +211,622 211,622
2024-07-17 Nighan Warren JR SVP Quality and Regulatory Grant or award +18,733 42,261
2024-07-17 Nighan Warren JR SVP Quality and Regulatory Grant or award · Performance Right +23,952 23,952
2024-07-17 Nighan Warren JR SVP Quality and Regulatory Grant or award · Non-Qualified Stock Option (right to buy) +23,507 23,507
2024-07-17 REED JAN STERN Director Grant or award +20,541 87,359
2024-07-17 JOHNSON WESLEY Director Grant or award +20,541 125,863
2024-07-17 DONNELLY HOWARD W Director Grant or award +20,541 149,376
2024-07-17 Burgess Lorinda Director Grant or award +20,541 37,582
2024-07-17 Trowbridge Stephen A EVP and CFO Grant or award +38,953 167,854
2024-07-17 Trowbridge Stephen A EVP and CFO Grant or award · Performance Right +77,905 77,905
2024-07-17 Trowbridge Stephen A EVP and CFO Grant or award · Non-Qualified Stock Option (right to buy) +76,458 76,458
2024-07-17 Licitra Karen A Director Grant or award +20,541 72,760
2024-07-17 Auen Eileen O'Shea Director Grant or award +20,541 87,043
2024-04-08 Clemmer James C President and CEO Purchase +10,000 $6.70 $67K 539,066
2024-02-29 Trowbridge Stephen A EVP and CFO Grant or award +1,927 $4.67 $9K 128,901
2023-07-21 Trowbridge Stephen A EVP and CFO Shares withheld for taxes −667 $8.65 $6K 114,595
2023-07-21 Clemmer James C President and CEO Shares withheld for taxes −3,372 $8.65 $29K 529,066
2023-07-21 Helsel Dave SVP Global Operations and R&D Shares withheld for taxes −365 $8.65 $3K 28,289

Page 8 of 21 · 415 trades